Valuation
Login to View
Max Portfolio %
Login to View
Last 7 days
13.7%
Last 30 days
18.5%
Last 90 days
99.4%
Trailing 12 Months
-79.9%
ADIL RSI Chart
Valuation
Login to View
Max Portfolio %
Login to View
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
How Adial Pharmaceuticals Inc generates revenue and covers its expenses, based on the latest reported earnings.
| CEO | Mr. Cary John Claiborne MBA |
|---|---|
| WEBSITE | adialpharma.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 16 |